After six months of collaboration, the Sagitta Pharma CSR partnership with PharmaGreen has produced its first concrete and measurable results, illustrating the laboratory's commitment to a more responsible pharmaceutical industry.
The objective is clear: to reduce waste, limit our environmental impact, and strengthen solidarity, while complying with a strict regulatory framework.
An initial assessment now allows us to measure the tangible results of this collaboration.
See the article announcing the launch of the project: https://entreprise.sagittapharma.com/un-partenariat-porteur-de-sens-pour-une-sante-plus-responsable-avec-pharmagreen/
The goal: to enable the reuse of unsellable pharmaceutical products destined for destruction, while having a real social and environmental impact.
This initial assessment allows us to evaluate the results of this collaboration in concrete terms.
Giving pharmaceutical products a second life
Launched with strong environmental and social ambitions, the partnership between Sagitta Pharma and PharmaGreen aims to give a second life to unsellable but still usable pharmaceutical products by redirecting them to secure solidarity channels.
This initiative is fully in line with Sagitta Pharma's CSR strategy and consistent with the current challenges facing the industry:
- waste reduction,
- limiting carbon footprint,
- support for people in precarious situations,
- promoting the circular economy in the healthcare sector.
A structured system
In six successive collections, 5,293 essential items were saved from destruction and reused in a supervised and supportive environment.
These products, which would have been disposed of through conventional channels, have thus been given a new social purpose.
Direct social impact thanks to partner associations
The collected items were redistributed through three major charitable networks in France and internationally:
- Île-de-France Food Bank
- Aviation Without Borders
- French People's Relief
Thanks to these redistributions, thousands of people in precarious situations, isolated or in emergency situations, have been able to access essential products, helping to improve their daily lives.
Reuse and the environment: a measured impact
Beyond the social issue, reusing products directly contributes to reducing Sagitta Pharma's environmental footprint.
By the end of December, the first collections had prevented 445 kg of CO₂ emissions, according to consolidated data from the system.
This impact corresponds in particular to:
- after traveling nearly 3,700 km by car,
- 3 flights from Paris to Marseille
- or several months of gas heating for a home.
These indicators make it possible to quantify the environmental impact of reuse, in line with a philosophy of moderation and the circular economy.
A CSR approach integrated into Sagitta Pharma's business
This partnership is fully in line with Sagitta Pharma's CSR strategy, which is based on three pillars:
- reduction of waste and refuse,
- meaningful and measurable social impact,
- Concrete solutions for players in the pharmaceutical industry.
In line with this approach, Sagitta Pharma also gives its customers access to this reuse system, offering them a simple, regulated solution tailored to the operational constraints of pharmacies.
A process now open to Sagitta Pharma customers
Since early 2026, this Pharmagreen system has been available to Sagitta Pharma customers, allowing them to easily integrate this responsible approach into their professional practice, while benefiting from a secure regulatory framework.
A dynamic set to continue
This initial assessment confirms the relevance of this approach to environmental and social responsibility, integrated into the realities on the ground.
In 2026, we intend to continue our partnership with PharmaGreen, with the ambition of further strengthening its impact in the service of a more responsible, committed, and supportive pharmaceutical industry.
